If someone becomes pregnant while taking a GLP-1, the key is not to panic, but to stop the medication and talk with a clinician about the safest path forward for both parent and baby
Request details on how side effects are managed, what happens if the medication is discontinued, and whether genetic or biomarker testing is offered
Most GLP-1 medications only target one hormone
Baykal-Caglar E, Hassan-Zadeh E, Saremi B, Huang J
The potential benefits of tirzepatide may include the following: Significant and sustained weight loss Tirzepatide is a dual GLP-1/GIP receptor agonist that helps significantly reduce body weight by enhancing insulin secretion, lowering glucagon levels, and delaying gastric emptying, which contribute to reduced calorie intake and weight loss
This medication is a bit stronger than Semaglutide because it works on two receptors -both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)